Cargando…

Impact of Statin Use on Outcomes in Triple Negative Breast Cancer

Purpose: We sought to investigate if the use of HMG Co-A reductase inhibitors (statins) has an impact on outcomes among patients with triple negative breast cancer (TNBC). Methods: We reviewed the cases of women with invasive, non-metastatic TNBC, diagnosed 1997-2012. Clinical outcomes were compared...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaitelman, Simona F., Stauder, Michael C., Allen, Pamela, Reddy, Sangeetha, Lakoski, Susan, Atkinson, Bradley, Reddy, Jay, Amaya, Diana, Guerra, William, Ueno, Naoto, Caudle, Abigail, Tereffe, Welela, Woodward, Wendy A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559964/ https://www.ncbi.nlm.nih.gov/pubmed/28819403 http://dx.doi.org/10.7150/jca.18743

Ejemplares similares

A component of lobular carcinoma in clinically lymph node–negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer
por: Van Wyhe, Renae D., et al.
Publicado: (2018)

Proton Partial Breast Irradiation: Detailed Description of Acute Clinico-Radiologic Effects
por: Ovalle, Valentina, et al.
Publicado: (2018)

The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer
por: Thaker, Nikhil G, et al.
Publicado: (2015)

Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation
por: Takiar, Vinita, et al.
Publicado: (2014)

Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer
por: Corrigan, Kelsey L., et al.
Publicado: (2021)

Use of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: A National Cancer Database analysis
por: Moreno, Amy C., et al.
Publicado: (2017)

Novel therapeutic strategies in the treatment of triple-negative breast cancer
por: Oualla, Karima, et al.
Publicado: (2017)

Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free Survival
por: Stecklein, Shane R., et al.
Publicado: (2017)

Targeting EGFR in Triple Negative Breast Cancer
por: Ueno, Naoto T., et al.
Publicado: (2011)

Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer
por: Bambhroliya, Arvind, et al.
Publicado: (2018)

Effect of statins on breast cancer recurrence and mortality: a review
por: Van Wyhe, Renae D, et al.
Publicado: (2017)

Survivorship and Advocacy in Inflammatory Breast Cancer
por: Alexander, Angela, et al.
Publicado: (2018)

Differences in Time Burden across Local Therapy Strategies for Early-stage Breast Cancer
por: Swanick, Cameron W., et al.
Publicado: (2021)

Accelerated partial-breast irradiation using intensity-modulated proton radiotherapy: do uncertainties outweigh potential benefits?
por: Wang, X, et al.
Publicado: (2013)

A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2‐Negative Breast Cancer
por: Lim, Bora, et al.
Publicado: (2020)

Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers
por: Li, Xiaotong, et al.
Publicado: (2021)

Aligning mission to digital health strategy in academic medical centers
por: Cohen, Adam B., et al.
Publicado: (2022)

Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells
por: O’Grady, Shane, et al.
Publicado: (2022)

Pleiotropic effects of statins
por: Kavalipati, Narasaraju, et al.
Publicado: (2015)

Targeting and limiting surgery for patients with node-positive breast cancer
por: Caudle, Abigail S., et al.
Publicado: (2015)

Statin use in primary inflammatory breast cancer: a cohort study
por: Brewer, T M, et al.
Publicado: (2013)

Severe Anti-HMG-CoAR Necrotizing Autoimmune Myopathy Secondary to Statin Use
por: Pulipati, Priyanjali, et al.
Publicado: (2022)

Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers
por: Masuda, Hiroko, et al.
Publicado: (2013)

Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype
por: Harano, Kenichi, et al.
Publicado: (2018)

Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging
por: Aldrich, Melissa B., et al.
Publicado: (2022)

EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer
por: Debeb, Bisrat G, et al.
Publicado: (2014)

Inclusion of premenopausal women in breast cancer clinical trials
por: Corrigan, Kelsey L., et al.
Publicado: (2022)

Treatment, Behavioral, and Psychosocial Components of Cardiovascular Disease Risk Among Survivors of Childhood and Young Adult Cancer
por: Berkman, Amy M., et al.
Publicado: (2015)

Triple Negative Breast Cancer – An Overview
por: Aysola, Kartik, et al.
Publicado: (2013)

The Effect of Doubling the Statin Dose on Pro-Inflammatory Cytokine in Patients With Triple-Vessel Coronary Artery Disease
por: Kim, Yoo Ri, et al.
Publicado: (2012)

Novel strategies to target chemoresistant triple-negative breast cancer
por: Venkatesh, Jaganathan, et al.
Publicado: (2020)

Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program
por: Gandhi, Anusha, et al.
Publicado: (2023)

Effects of statins on mitochondrial pathways
por: Mollazadeh, Hamid, et al.
Publicado: (2021)

Mast Cells: A New Frontier for Cancer Immunotherapy
por: Lichterman, Jake N., et al.
Publicado: (2021)

STATIN INDUCED NECROTIZING AUTOIMMUNE MYOPATHY WITHOUT CONCURRENT STATIN USE: YET ANOTHER SEQUELA OF COVID-19?
por: Jaffry, Hassam, et al.
Publicado: (2022)

Statin Intolerance and Suboptimal Statin Therapy
por: Tada, Hayato, et al.
Publicado: (2019)

Statin-induced necrotizing autoimmune myopathy: a systematic review
por: Somagutta, Manoj Kumar Reddy, et al.
Publicado: (2022)

Impact of combination therapy with statin and ezetimibe on secondary prevention for post-acute myocardial infarction patients in the statin era
por: Ebisawa, Soichiro, et al.
Publicado: (2015)

Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype
por: Funakoshi, Yohei, et al.
Publicado: (2019)

Statins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiency
por: Jung, Hae Hyun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rk8k366q4kadv82pful5nei0p5